Literature DB >> 16565537

Kyphoplasty: chances and limits.

Christian W Mueller1, Ulrich Berlemann.   

Abstract

Kyphoplasty provides a minimal-invasive surgical technique for the cement augmentation of vertebral bodies following osteoprotic compression fractures or malignant processes. Kyphoplasty has been developed as an advancement of vertebroplasty. Both procedures feature high-success rates in terms of reliable and lasting reduction of pain. Advantages of kyphoplasty over vertebroplasty are to be seen in the possibility of deformity correction as well as in a decreased risk of cement leakage, which represents the most important source for clinical complications. Long-term experiences with the effect of cementing vertebral bodies are sparse. Thus indications and possibilities have to be judged realistically. Conditions, which have to be considered before performing kyphoplasty or vertebroplasty include age of the patient, age of the fracture, degree of deformation and additional degenerative changes of the spine. This article summarizes the present research and literature as well as indications and contraindications and is thought to provide guidelines for the aforementioned decision-making processes.

Entities:  

Mesh:

Year:  2005        PMID: 16565537     DOI: 10.4103/0028-3886.22612

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  2 in total

1.  Is intervertebral cement leakage a risk factor for new adjacent vertebral collapse?

Authors:  Anchalee Churojana; Dittapong Songsaeng; Rujimas Khumtong; Anek Suwanbundit; Guillaume Saliou
Journal:  Interv Neuroradiol       Date:  2014-10-17       Impact factor: 1.610

2.  Restoration of spinal alignment and disk mechanics following polyetheretherketone wafer kyphoplasty with StaXx FX.

Authors:  S M Renner; P P Tsitsopoulos; A T Dimitriadis; L I Voronov; R M Havey; G Carandang; B McIntosh; C Carson; D Ty; J G Ringelstein; A G Patwardhan
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-16       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.